Evidence map›Paper›PMID 42513150›Full record

ReviewMolecules (Basel, Switzerland)2026

Intelligent Hydrocolloid-Based Delivery Systems: Innovations in Pharmacy and Cosmetics.

Karen Khachatryan, Oskar Michalski, Klaudia Michalska

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karen KhachatryanLaboratory of Nanotechnology and Nanomaterials, Faculty of Food Technology, University of Agriculture in Krakow, Al. Mickiewicza 21, 31-120 Krakow, Poland.ORCID 0000-0001-7823-5406
Oskar MichalskiDepartment of Chemistry, Faculty of Food Technology, University of Agriculture in Krakow, Al. Mickiewicza 21, 31-120 Krakow, Poland.
Klaudia MichalskaDepartment of Phytochemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna Street 12, 31-343 Krakow, Poland.ORCID 0000-0003-1372-1408

Funding

Ministry of Science and Higher Education Subsidy for the University of Agriculture in Krakow for 2025
6 · The paper itself

Abstract

Hydrocolloid-based and hydrocolloid-dominant hybrid matrices have developed from conventional rheology modifiers into functional platforms for pharmaceutical and cosmetic delivery. This review focuses on systems in which hydrocolloid chemistry, hydration, ionisation, bioadhesion, and network architecture determine swelling, mechanical behaviour, biocompatibility, and controlled release. The discussion covers alginate, chitosan, hyaluronic acid, pectin, carrageenan, dextran, gellan gum, collagen, cellulose derivatives, and selected hybrid architectures in which synthetic or semi-synthetic components provide a defined responsive function. Rather than treating all smart polymers as a single class, the review compares how pH, enzymatic, redox/ROS, thermo-responsive, magnetic, optical, ultrasound-mediated, and multi-trigger mechanisms operate within hydrocolloid-rich matrices. Pharmaceutical examples are considered across oral, transdermal, injectable depot, wound-healing, and regenerative applications, while cosmetic and cosmeceutical systems are discussed in relation to active stabilisation, dermal residence, barrier support, and personalised skincare. By linking material class, trigger mechanism, route of administration, and translational constraints, the review identifies the main advantages of hydrocolloids as delivery matrices as well as their current limitations, including burst release, modest mechanical strength, hydrophobic-drug loading challenges, sterilisation sensitivity, source variability, and regulatory complexity.

Indexed as

CosmeticsDrug Delivery SystemsColloidsHumansColloidsCosmetics3D bioprintingcosmeceuticalshybrid hydrogelshydrocolloid-based delivery systemsinjectable depotsnatural polysaccharidesoral delivery systemsstimuli-responsive releasetheranostic smart patchestransdermal patcheswound dressings

Identifiers

PMID42513150
PMCPMC13416492

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.